Laurion Capital Management LP Meridian Bioscience Inc Transaction History

Laurion Capital Management LP

  • $5.23 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$9.17 - $12.01 $121,704 - $159,396
-13,272 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$10.88 - $17.6 $144,399 - $233,587
13,272 New
13,272 $158,000
Q3 2018

Nov 13, 2018
SELL
$14.85 - $16.35 $307,365 - $338,412
-20,698 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$13.8 - $16.8 $285,632 - $347,726
20,698 New
20,698 $329,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email